December 11, 2025/
Prescriber Update is a quarterly medical safety publication issued by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. It is intended for healthcare professionals to communicate...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
Prescriber Update is a quarterly medical safety publication issued by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. It is intended for healthcare professionals to communicate...
This document is an official publication from the European Medicines Agency (EMA) detailing the safety recommendations made by its Pharmacovigilance Risk Assessment Committee (PRAC) following its meeting from 27–30 October...
Lock therapy (also called catheter lock therapy or antibiotic lock therapy - ALT) refers to a technique where a high-concentration antimicrobial or anticoagulant solution is instilled into the lumen of an indwelling...
